Patent · US Active

B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide

US9676855B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Deutsches Krebsforschungszentrum · DE

Inventors

Adelheid Cerwenka · Heidelberg, DE
Gerhard Moldenhauer · Heidelberg, DE

Key dates

Filing date	Sep 10, 2012
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Dec 1, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/24
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is concerned with diagnostic methods and means. Specifically, it relates to an antibody which specifically binds to a portion of the extracellular domain of the B7-H6 polypeptide. Moreover, said antibody is provided for use in the treatment or diagnosis of cancer or inflammatory disease. Furthermore, provided are a method for diagnosing cancer in a sample of a subject suspected to suffer from cancer or an inflammatory disease. Further, the present invention concerns a device and a kit for diagnosing cancer or an inflammatory.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.